The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

DSpace Repository

The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer

Author: Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kuemmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Ludtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Wuerstlein, Rachel; Kates, Ronald E.; Harbeck, Nadia
Tübinger Autor(en):
Grischke, Eva-Maria
Published in: Therapeutic Advances in Medical Oncology (2020), Bd. 12, Article 1758835920973130
Verlagsangabe: Sage Publications Ltd
Language: English
Full text: http://dx.doi.org/10.1177/1758835920973130
ISSN: 1758-8359
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)